, Jieun Hwang2,3
1Office of Public Healthcare, National Medical Center, Seoul, Korea
2Department of Health Administration, Dankook University College of Health Science, Cheonan, Korea
3Institute of Convergence Healthcare, Dankook University, Cheonan, Korea
© 2026, Korean Society of Epidemiology
This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Conflict of interest
The authors have no conflicts of interest to declare for this study.
Funding
This research was supported by the publication fee support from the Researcher Support Project of the Public Health and Medical Research Institute of the National Medical Center.
Acknowledgements
This article is based on the doctoral dissertation Jeong Min Yang in 2025. We would like to thank colleagues from the Department of Public Health, Graduate School of Dankook University, who provided their advice in the preparation of this manuscript.
Author contributions
Both authors contributed equally to conceiving the study, analyzing the data, and writing this paper.
| Characteristics | Total |
All-cause mortality |
p-value (effect size)1 |
Cancer mortality |
p-value (effect size)1 |
CVD mortality |
p-value (effect size)1 |
|---|---|---|---|---|---|---|---|
| Death | Death | Death | |||||
| Disability | <0.001 | <0.001 | <0.001 | ||||
| Normal | 87,387 (91.8) | 7,205 (8.2) | - | 3,091 (3.5) | - | 1,128 (1.3) | - |
| Mild | 6,041 (6.3) | 967 (16.0) | (0.22) | 332 (5.5) | (0.09) | 194 (3.2) | (0.13) |
| Severe | 1,798 (1.9) | 465 (25.9) | (0.44) | 126 (7.0) | (0.15) | 96 (5.3) | (0.23) |
| CCI | <0.001 | <0.001 | <0.001 | ||||
| 0 | 65,317 (68.6) | 4,610 (7.1) | - | 1,964 (3.0) | - | 770 (1.2) | - |
| 1 | 24,370 (25.6) | 2,862 (11.7) | (0.15) | 1,141 (4.7) | (0.08) | 468 (1.9) | (0.06) |
| 2 | 4,736 (5.0) | 915 (19.3) | (0.34) | 323 (6.8) | (0.17) | 141 (3.0) | (0.13) |
| ≥3 | 803 (0.8) | 250 (31.1) | (0.59) | 121 (15.1) | (0.43) | 39 (4.9) | (0.22) |
| Female | |||||||
| Total | 72,117 (100) | 3,856 (5.3) | 1,286 (1.8) | 926 (1.3) | |||
| Health behavior trajectory | <0.001 | <0.001 | <0.001 | ||||
| Moderate risk | 7,382 (10.2) | 330 (4.5) | (0.43) | 112 (1.5) | (0.25) | 72 (1.0) | (0.20) |
| Stable healthy | 25,045 (34.7) | 1,317 (5.3) | - | 409 (1.6) | - | 294 (1.2) | - |
| Low risk | 17,198 (23.8) | 921 (5.4) | (0.47) | 302 (1.8) | (0.27) | 217 (1.3) | (0.23) |
| Mild risk | 16,916 (23.5) | 1,060 (6.3) | (0.51) | 369 (2.2) | (0.30) | 287 (1.7) | (0.26) |
| Decreasing risk | 4,927 (6.8) | 147 (3.0) | (0.35) | 69 (1.4) | (0.24) | 31 (0.6) | (0.16) |
| Severe risk | 649 (0.9) | 81 (12.5) | (0.72) | 25 (3.9) | (0.40) | 25 (3.9) | (0.40) |
| Age (yr) | <0.001 | <0.001 | <0.001 | ||||
| <55 | 31,309 (43.4) | 347 (1.1) | - | 202 (0.6) | - | 41 (0.1) | - |
| 55-64 | 25,974 (36.0) | 709 (2.7) | (0.33) | 373 (1.4) | (0.24) | 120 (0.5) | (0.14) |
| 65-74 | 11,149 (15.5) | 1,516 (13.6) | (0.76) | 478 (4.3) | (0.42) | 394 (3.5) | (0.38) |
| 75-84 | 3,633 (5.0) | 1,254 (34.5) | (1.26) | 228 (6.3) | (0.51) | 363 (10.0) | (0.64) |
| ≥85 | 52 (0.1) | 30 (57.7) | (1.73) | 5 (9.6) | (0.63) | 8 (15.4) | (0.81) |
| Region | <0.001 | 0.002 | <0.001 | ||||
| Capital area | 29,987 (41.6) | 1,375 (4.6) | - | 517 (1.7) | - | 317 (1.1) | - |
| Metropolitan area | 15,872 (22.0) | 742 (4.7) | (0.44) | 246 (1.5) | (0.25) | 174 (1.1) | (0.21) |
| Other areas | 26,258 (36.4) | 1,739 (6.6) | (0.52) | 523 (2.0) | (0.28) | 435 (1.7) | (0.26) |
| Medical insurance | <0.001 | <0.001 | <0.001 | ||||
| National Health Insurance (region) | 19,272 (26.7) | 1,426 (7.4) | - | 441 (2.3) | - | 365 (1.9) | - |
| National Health Insurance (workplace) | 52,727 (73.1) | 2,406 (4.6) | (0.43) | 840 (1.6) | (0.25) | 552 (1.0) | (0.20) |
| Medical Aid | 118 (0.2) | 24 (20.3) | (0.94) | 5 (4.2) | (0.41) | 9 (7.6) | (0.56) |
| Income level | <0.001 | 0.051 | 0.025 | ||||
| Low | 16,979 (23.5) | 1,019 (6.0) | - | 311 (1.8) | - | 249 (1.5) | - |
| Mid | 24,640 (34.2) | 1,201 (4.9) | (0.49) | 399 (1.6) | (0.27) | 319 (1.3) | (0.24) |
| High | 30,498 (42.3) | 1,636 (5.4) | (0.45) | 576 (1.9) | (0.26) | 358 (1.2) | (0.23) |
| Disability | <0.001 | <0.001 | <0.001 | ||||
| Normal | 67,669 (93.8) | 3,319 (4.9) | - | 1,148 (1.7) | - | 777 (1.1) | - |
| Mild | 3,631 (5.0) | 398 (11.0) | (0.67) | 115 (3.2) | (0.36) | 106 (2.9) | (0.34) |
| Severe | 817 (1.1) | 139 (17.0) | (0.85) | 23 (2.8) | (0.34) | 43 (5.3) | (0.46) |
| CCI | <0.001 | <0.001 | <0.001 | ||||
| 0 | 44,009 (61.0) | 1,891 (4.3) | - | 673 (1.5) | - | 431 (1.0) | - |
| 1 | 21,672 (30.1) | 1,335 (6.2) | (0.50) | 439 (2.0) | (0.29) | 325 (1.5) | (0.25) |
| 2 | 5,472 (7.6) | 470 (8.6) | (0.59) | 124 (2.3) | (0.30) | 121 (2.2) | (0.30) |
| ≥3 | 964 (1.3) | 160 (16.6) | (0.84) | 50 (5.2) | (0.46) | 49 (5.1) | (0.45) |
| Variables | 1-yr | 3-yr | 5-yr | 7-yr | Entire period |
|---|---|---|---|---|---|
| Male | |||||
| All-cause mortality | |||||
| Health behavior trajectory | |||||
| Higher moderate risk | 1.00 (0.93, 1.07) | 1.06 (0.99, 1.13) | 1.22 (1.14, 1.31)* | 1.42 (1.33, 1.52)* | 1.66 (1.56, 1.78)* |
| Higher severe risk | 0.88 (0.71, 1.09) | 0.94 (0.76, 1.17) | 1.17 (0.94, 1.45) | 1.45 (1.17, 1.80)* | 2.02 (1.63, 2.51)* |
| Stable healthy | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| Decreasing risk | 0.99 (0.92, 1.06) | 0.99 (0.92, 1.06) | 0.99 (0.92, 1.05) | 0.97 (0.91, 1.04) | 0.91 (0.85, 0.97)* |
| Lower severe risk | 1.14 (0.97, 1.35) | 1.21 (1.03, 1.43)* | 1.46 (1.23, 1.72)* | 1.79 (1.51, 2.11)* | 2.11 (1.79, 2.49)* |
| Lower moderate risk | 0.98 (0.90, 1.06) | 1.02 (0.94, 1.10) | 1.14 (1.05, 1.23)* | 1.26 (1.17, 1.37)* | 1.37 (1.27, 1.48)* |
| Cancer cause mortality | |||||
| Health behavior trajectory | |||||
| Higher moderate risk | 1.11 (0.99, 1.24) | 1.19 (1.06, 1.33)* | 1.40 (1.25, 1.57)* | 1.64 (1.47, 1.83)* | 1.94 (1.74, 2.17)* |
| Higher severe risk | 1.06 (0.77, 1.46) | 1.16 (0.84, 1.60) | 1.47 (1.07, 2.02)* | 1.87 (1.36, 2.57)* | 2.54 (1.85, 3.48)* |
| Stable healthy | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| Decreasing risk | 1.12 (1.00, 1.25) | 1.11 (0.99, 1.24) | 1.17 (1.00, 1.25) | 1.11 (0.99, 1.24) | 1.07 (0.95, 1.19) |
| Lower severe risk | 0.76 (0.54, 1.07) | 0.82 (0.58, 1.16) | 1.00 (0.71, 1.42) | 1.25 (0.88, 1.76) | 1.50 (1.06, 2.12)* |
| Lower moderate risk | 1.18 (1.05, 1.34)* | 1.25 (1.10, 1.41)* | 1.42 (1.25, 1.59)* | 1.59 (1.41, 1.79)* | 1.74 (1.54, 1.96)* |
| CVD cause mortality | |||||
| Health behavior trajectory | |||||
| Higher moderate risk | 0.97 (0.82, 1.16) | 1.02 (0.85, 1.21) | 1.16 (0.98, 1.38) | 1.33 (1.12, 1.58)* | 1.53 (1.29, 1.82)* |
| Higher severe risk | 1.46 (0.92, 2.30) | 1.54 (0.98, 2.44) | 1.87 (1.19, 2.95)* | 2.28 (1.45, 3.60)* | 3.17 (2.01, 4.99)* |
| Stable healthy | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| Decreasing risk | 1.12 (0.95, 1.32) | 1.11 (0.95, 1.31) | 1.11 (0.94, 1.31) | 1.08 (0.92, 1.27) | 0.98 (0.84, 1.16) |
| Lower severe risk | 1.17 (0.78, 1.76) | 1.23 (0.82, 1.85) | 1.45 (0.96, 2.17) | 1.74 (1.16, 2.62)* | 2.00 (1.33, 3.01)* |
| Lower moderate risk | 1.05 (0.86, 1.28) | 1.09 (0.89, 1.32) | 1.20 (0.99, 1.46) | 1.31 (1.08, 1.59)* | 1.39 (1.15, 1.69)* |
| Female | |||||
| All-cause mortality | |||||
| Health behavior trajectory | |||||
| Moderate risk | 1.02 (0.89, 1.17) | 1.05 (0.92, 1.21) | 1.13 (0.98, 1.30) | 1.21 (1.06, 1.39)* | 1.25 (1.09, 1.44)* |
| Stable healthy | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| Low risk | 0.98 (0.89, 1.08) | 0.98 (0.89, 1.08) | 0.98 (0.89, 1.07) | 0.96 (0.87, 1.06) | 0.95 (0.86, 1.04) |
| Mild risk | 1.01 (0.92, 1.11) | 1.00 (0.91, 1.10) | 1.00 (0.91, 1.09) | 0.97 (0.89, 1.07) | 0.87 (0.72, 1.05) |
| Decreasing risk | 0.83 (0.68, 1.00) | 0.83 (0.69, 1.00) | 0.82 (0.68, 0.99)* | 0.80 (0.66, 0.96)* | 0.90 (0.82, 0.99)* |
| Severe risk | 1.13 (0.88, 1.45) | 1.17 (0.91, 1.49) | 1.32 (1.03, 1.69)* | 1.56 (1.22, 2.00)* | 1.83 (1.43, 2.34)* |
| Cancer cause mortality | |||||
| Health behavior trajectory | |||||
| Moderate risk | 0.95 (0.75, 1.21) | 0.96 (0.75, 1.23) | 1.03 (0.80, 1.32) | 1.12 (0.87, 1.43) | 1.21 (0.94, 1.55) |
| Stable healthy | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| Low risk | 1.01 (0.86, 1.19) | 1.03 (0.86, 1.22) | 1.03 (0.86, 1.22) | 1.01 (0.85, 1.20) | 1.01 (0.85, 1.20) |
| Mild risk | 1.16 (0.99, 1.35) | 1.18 (1.00, 1.39) | 1.16 (0.98, 1.37) | 1.14 (0.97, 1.34) | 1.09 (0.93, 1.28) |
| Decreasing risk | 1.04 (0.79, 1.37) | 1.08 (0.81, 1.44) | 1.07 (0.81, 1.43) | 1.05 (0.79, 1.40) | 1.14 (0.86, 1.52) |
| Severe risk | 1.16 (0.75, 1.79) | 1.19 (0.74, 1.90) | 1.39 (0.87, 2.22) | 1.67 (1.05, 2.67)* | 1.91 (1.20, 3.05)* |
| CVD cause mortality | |||||
| Health behavior trajectory | |||||
| Moderate risk | 1.17 (0.87, 1.58) | 1.21 (0.90, 1.63) | 1.29 (0.96, 1.74) | 1.43 (1.08, 1.89)* | 1.43 (1.08, 1.89)* |
| Stable healthy | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| Low risk | 1.14 (0.93, 1.39) | 1.14 (0.93, 1.39) | 1.13 (0.92, 1.38) | 1.07 (0.88, 1.29) | 1.04 (0.86, 1.26) |
| Mild risk | 1.25 (1.04, 1.52)* | 1.25 (1.03, 1.51)* | 1.24 (1.02, 1.50)* | 1.19 (1.00, 1.43) | 1.11 (0.93, 1.33) |
| Decreasing risk | 0.93 (0.61, 1.40) | 0.92 (0.61, 1.38) | 0.89 (0.59, 1.34) | 0.88 (0.60, 1.29) | 0.98 (0.67, 1.45) |
| Severe risk | 1.70 (1.10, 2.62)* | 1.75 (1.14, 2.71)* | 1.97 (1.28, 3.04)* | 2.25 (1.48, 3.41)* | 2.68 (1.77, 4.05)* |
| Characteristics | Total | All-cause mortality |
p-value (effect size) |
Cancer mortality |
p-value (effect size) |
CVD mortality |
p-value (effect size) |
|---|---|---|---|---|---|---|---|
| Death | Death | Death | |||||
| Disability | <0.001 | <0.001 | <0.001 | ||||
| Normal | 87,387 (91.8) | 7,205 (8.2) | - | 3,091 (3.5) | - | 1,128 (1.3) | - |
| Mild | 6,041 (6.3) | 967 (16.0) | (0.22) | 332 (5.5) | (0.09) | 194 (3.2) | (0.13) |
| Severe | 1,798 (1.9) | 465 (25.9) | (0.44) | 126 (7.0) | (0.15) | 96 (5.3) | (0.23) |
| CCI | <0.001 | <0.001 | <0.001 | ||||
| 0 | 65,317 (68.6) | 4,610 (7.1) | - | 1,964 (3.0) | - | 770 (1.2) | - |
| 1 | 24,370 (25.6) | 2,862 (11.7) | (0.15) | 1,141 (4.7) | (0.08) | 468 (1.9) | (0.06) |
| 2 | 4,736 (5.0) | 915 (19.3) | (0.34) | 323 (6.8) | (0.17) | 141 (3.0) | (0.13) |
| ≥3 | 803 (0.8) | 250 (31.1) | (0.59) | 121 (15.1) | (0.43) | 39 (4.9) | (0.22) |
| Female | |||||||
| Total | 72,117 (100) | 3,856 (5.3) | 1,286 (1.8) | 926 (1.3) | |||
| Health behavior trajectory | <0.001 | <0.001 | <0.001 | ||||
| Moderate risk | 7,382 (10.2) | 330 (4.5) | (0.43) | 112 (1.5) | (0.25) | 72 (1.0) | (0.20) |
| Stable healthy | 25,045 (34.7) | 1,317 (5.3) | - | 409 (1.6) | - | 294 (1.2) | - |
| Low risk | 17,198 (23.8) | 921 (5.4) | (0.47) | 302 (1.8) | (0.27) | 217 (1.3) | (0.23) |
| Mild risk | 16,916 (23.5) | 1,060 (6.3) | (0.51) | 369 (2.2) | (0.30) | 287 (1.7) | (0.26) |
| Decreasing risk | 4,927 (6.8) | 147 (3.0) | (0.35) | 69 (1.4) | (0.24) | 31 (0.6) | (0.16) |
| Severe risk | 649 (0.9) | 81 (12.5) | (0.72) | 25 (3.9) | (0.40) | 25 (3.9) | (0.40) |
| Age (yr) | <0.001 | <0.001 | <0.001 | ||||
| <55 | 31,309 (43.4) | 347 (1.1) | - | 202 (0.6) | - | 41 (0.1) | - |
| 55-64 | 25,974 (36.0) | 709 (2.7) | (0.33) | 373 (1.4) | (0.24) | 120 (0.5) | (0.14) |
| 65-74 | 11,149 (15.5) | 1,516 (13.6) | (0.76) | 478 (4.3) | (0.42) | 394 (3.5) | (0.38) |
| 75-84 | 3,633 (5.0) | 1,254 (34.5) | (1.26) | 228 (6.3) | (0.51) | 363 (10.0) | (0.64) |
| ≥85 | 52 (0.1) | 30 (57.7) | (1.73) | 5 (9.6) | (0.63) | 8 (15.4) | (0.81) |
| Region | <0.001 | 0.002 | <0.001 | ||||
| Capital area | 29,987 (41.6) | 1,375 (4.6) | - | 517 (1.7) | - | 317 (1.1) | - |
| Metropolitan area | 15,872 (22.0) | 742 (4.7) | (0.44) | 246 (1.5) | (0.25) | 174 (1.1) | (0.21) |
| Other areas | 26,258 (36.4) | 1,739 (6.6) | (0.52) | 523 (2.0) | (0.28) | 435 (1.7) | (0.26) |
| Medical insurance | <0.001 | <0.001 | <0.001 | ||||
| National Health Insurance (region) | 19,272 (26.7) | 1,426 (7.4) | - | 441 (2.3) | - | 365 (1.9) | - |
| National Health Insurance (workplace) | 52,727 (73.1) | 2,406 (4.6) | (0.43) | 840 (1.6) | (0.25) | 552 (1.0) | (0.20) |
| Medical Aid | 118 (0.2) | 24 (20.3) | (0.94) | 5 (4.2) | (0.41) | 9 (7.6) | (0.56) |
| Income level | <0.001 | 0.051 | 0.025 | ||||
| Low | 16,979 (23.5) | 1,019 (6.0) | - | 311 (1.8) | - | 249 (1.5) | - |
| Mid | 24,640 (34.2) | 1,201 (4.9) | (0.49) | 399 (1.6) | (0.27) | 319 (1.3) | (0.24) |
| High | 30,498 (42.3) | 1,636 (5.4) | (0.45) | 576 (1.9) | (0.26) | 358 (1.2) | (0.23) |
| Disability | <0.001 | <0.001 | <0.001 | ||||
| Normal | 67,669 (93.8) | 3,319 (4.9) | - | 1,148 (1.7) | - | 777 (1.1) | - |
| Mild | 3,631 (5.0) | 398 (11.0) | (0.67) | 115 (3.2) | (0.36) | 106 (2.9) | (0.34) |
| Severe | 817 (1.1) | 139 (17.0) | (0.85) | 23 (2.8) | (0.34) | 43 (5.3) | (0.46) |
| CCI | <0.001 | <0.001 | <0.001 | ||||
| 0 | 44,009 (61.0) | 1,891 (4.3) | - | 673 (1.5) | - | 431 (1.0) | - |
| 1 | 21,672 (30.1) | 1,335 (6.2) | (0.50) | 439 (2.0) | (0.29) | 325 (1.5) | (0.25) |
| 2 | 5,472 (7.6) | 470 (8.6) | (0.59) | 124 (2.3) | (0.30) | 121 (2.2) | (0.30) |
| ≥3 | 964 (1.3) | 160 (16.6) | (0.84) | 50 (5.2) | (0.46) | 49 (5.1) | (0.45) |
| Variables | 1-yr | 3-yr | 5-yr | 7-yr | Entire period |
|---|---|---|---|---|---|
| Male | |||||
| All-cause mortality | |||||
| Health behavior trajectory | |||||
| Higher moderate risk | 1.00 (0.93, 1.07) | 1.06 (0.99, 1.13) | 1.22 (1.14, 1.31) |
1.42 (1.33, 1.52) |
1.66 (1.56, 1.78) |
| Higher severe risk | 0.88 (0.71, 1.09) | 0.94 (0.76, 1.17) | 1.17 (0.94, 1.45) | 1.45 (1.17, 1.80) |
2.02 (1.63, 2.51) |
| Stable healthy | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| Decreasing risk | 0.99 (0.92, 1.06) | 0.99 (0.92, 1.06) | 0.99 (0.92, 1.05) | 0.97 (0.91, 1.04) | 0.91 (0.85, 0.97) |
| Lower severe risk | 1.14 (0.97, 1.35) | 1.21 (1.03, 1.43) |
1.46 (1.23, 1.72) |
1.79 (1.51, 2.11) |
2.11 (1.79, 2.49) |
| Lower moderate risk | 0.98 (0.90, 1.06) | 1.02 (0.94, 1.10) | 1.14 (1.05, 1.23) |
1.26 (1.17, 1.37) |
1.37 (1.27, 1.48) |
| Cancer cause mortality | |||||
| Health behavior trajectory | |||||
| Higher moderate risk | 1.11 (0.99, 1.24) | 1.19 (1.06, 1.33) |
1.40 (1.25, 1.57) |
1.64 (1.47, 1.83) |
1.94 (1.74, 2.17) |
| Higher severe risk | 1.06 (0.77, 1.46) | 1.16 (0.84, 1.60) | 1.47 (1.07, 2.02) |
1.87 (1.36, 2.57) |
2.54 (1.85, 3.48) |
| Stable healthy | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| Decreasing risk | 1.12 (1.00, 1.25) | 1.11 (0.99, 1.24) | 1.17 (1.00, 1.25) | 1.11 (0.99, 1.24) | 1.07 (0.95, 1.19) |
| Lower severe risk | 0.76 (0.54, 1.07) | 0.82 (0.58, 1.16) | 1.00 (0.71, 1.42) | 1.25 (0.88, 1.76) | 1.50 (1.06, 2.12) |
| Lower moderate risk | 1.18 (1.05, 1.34) |
1.25 (1.10, 1.41) |
1.42 (1.25, 1.59) |
1.59 (1.41, 1.79) |
1.74 (1.54, 1.96) |
| CVD cause mortality | |||||
| Health behavior trajectory | |||||
| Higher moderate risk | 0.97 (0.82, 1.16) | 1.02 (0.85, 1.21) | 1.16 (0.98, 1.38) | 1.33 (1.12, 1.58) |
1.53 (1.29, 1.82) |
| Higher severe risk | 1.46 (0.92, 2.30) | 1.54 (0.98, 2.44) | 1.87 (1.19, 2.95) |
2.28 (1.45, 3.60) |
3.17 (2.01, 4.99) |
| Stable healthy | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| Decreasing risk | 1.12 (0.95, 1.32) | 1.11 (0.95, 1.31) | 1.11 (0.94, 1.31) | 1.08 (0.92, 1.27) | 0.98 (0.84, 1.16) |
| Lower severe risk | 1.17 (0.78, 1.76) | 1.23 (0.82, 1.85) | 1.45 (0.96, 2.17) | 1.74 (1.16, 2.62) |
2.00 (1.33, 3.01) |
| Lower moderate risk | 1.05 (0.86, 1.28) | 1.09 (0.89, 1.32) | 1.20 (0.99, 1.46) | 1.31 (1.08, 1.59) |
1.39 (1.15, 1.69) |
| Female | |||||
| All-cause mortality | |||||
| Health behavior trajectory | |||||
| Moderate risk | 1.02 (0.89, 1.17) | 1.05 (0.92, 1.21) | 1.13 (0.98, 1.30) | 1.21 (1.06, 1.39) |
1.25 (1.09, 1.44) |
| Stable healthy | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| Low risk | 0.98 (0.89, 1.08) | 0.98 (0.89, 1.08) | 0.98 (0.89, 1.07) | 0.96 (0.87, 1.06) | 0.95 (0.86, 1.04) |
| Mild risk | 1.01 (0.92, 1.11) | 1.00 (0.91, 1.10) | 1.00 (0.91, 1.09) | 0.97 (0.89, 1.07) | 0.87 (0.72, 1.05) |
| Decreasing risk | 0.83 (0.68, 1.00) | 0.83 (0.69, 1.00) | 0.82 (0.68, 0.99) |
0.80 (0.66, 0.96) |
0.90 (0.82, 0.99) |
| Severe risk | 1.13 (0.88, 1.45) | 1.17 (0.91, 1.49) | 1.32 (1.03, 1.69) |
1.56 (1.22, 2.00) |
1.83 (1.43, 2.34) |
| Cancer cause mortality | |||||
| Health behavior trajectory | |||||
| Moderate risk | 0.95 (0.75, 1.21) | 0.96 (0.75, 1.23) | 1.03 (0.80, 1.32) | 1.12 (0.87, 1.43) | 1.21 (0.94, 1.55) |
| Stable healthy | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| Low risk | 1.01 (0.86, 1.19) | 1.03 (0.86, 1.22) | 1.03 (0.86, 1.22) | 1.01 (0.85, 1.20) | 1.01 (0.85, 1.20) |
| Mild risk | 1.16 (0.99, 1.35) | 1.18 (1.00, 1.39) | 1.16 (0.98, 1.37) | 1.14 (0.97, 1.34) | 1.09 (0.93, 1.28) |
| Decreasing risk | 1.04 (0.79, 1.37) | 1.08 (0.81, 1.44) | 1.07 (0.81, 1.43) | 1.05 (0.79, 1.40) | 1.14 (0.86, 1.52) |
| Severe risk | 1.16 (0.75, 1.79) | 1.19 (0.74, 1.90) | 1.39 (0.87, 2.22) | 1.67 (1.05, 2.67) |
1.91 (1.20, 3.05) |
| CVD cause mortality | |||||
| Health behavior trajectory | |||||
| Moderate risk | 1.17 (0.87, 1.58) | 1.21 (0.90, 1.63) | 1.29 (0.96, 1.74) | 1.43 (1.08, 1.89) |
1.43 (1.08, 1.89) |
| Stable healthy | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
| Low risk | 1.14 (0.93, 1.39) | 1.14 (0.93, 1.39) | 1.13 (0.92, 1.38) | 1.07 (0.88, 1.29) | 1.04 (0.86, 1.26) |
| Mild risk | 1.25 (1.04, 1.52) |
1.25 (1.03, 1.51) |
1.24 (1.02, 1.50) |
1.19 (1.00, 1.43) | 1.11 (0.93, 1.33) |
| Decreasing risk | 0.93 (0.61, 1.40) | 0.92 (0.61, 1.38) | 0.89 (0.59, 1.34) | 0.88 (0.60, 1.29) | 0.98 (0.67, 1.45) |
| Severe risk | 1.70 (1.10, 2.62) |
1.75 (1.14, 2.71) |
1.97 (1.28, 3.04) |
2.25 (1.48, 3.41) |
2.68 (1.77, 4.05) |
Values are presented as number (%). CVD, cardiovascular disease; CCI, Charlson comorbidity index. Effect sizes are presented as Cohen’s
Values are presented as hazard ratio (95% confidence interval); All covariates were controlled. CVD, cardiovascular disease. p<0.05.